Colitis induced by IL-17A-inhibitors.
Lea GrümmeSophia DombretThomas KnöselAlla SkapenkoHendrik Schulze-KoopsPublished in: Clinical journal of gastroenterology (2023)
The role of IL-17A inhibitors in the pathogenesis of infectious colitis and new-onset IBD is not fully understood and requires further research. Patients receiving IL-17A-inhibitor therapy should be carefully screened and notified of the possible side effects.
Keyphrases